Macrogenics Inc’s recently made public that its Senior VP and General Counsel Peters Jeffrey Stuart unloaded Company’s shares for reported $0.8 million on Apr 04 ’24. In the deal valued at $15.55 per share,51,395 shares were sold. As a result of this transaction, Peters Jeffrey Stuart now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Peters Jeffrey Stuart sold 19,625 shares, generating $421,938 in total proceeds. Upon selling the shares at $21.50, the Senior VP and General Counsel now owns 8,895 shares.
Before that, Risser Eric Blasius sold 41,159 shares. Macrogenics Inc shares valued at $813,501 were divested by the Chief Operating Officer at a price of $19.76 per share. As a result of the transaction, Risser Eric Blasius now holds 38,900 shares, worth roughly $0.14 million.
BTIG Research downgraded its Macrogenics Inc [MGNX] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in late July from “a Buy” to “a Neutral”. B. Riley Securities also remained covering MGNX and has decreased its forecast on July 31, 2024 with a “Neutral” recommendation from previously “Buy” rating. TD Cowen revised its rating on May 10, 2024. It rated MGNX as “a Hold” which previously was an “a Buy”.
Price Performance Review of MGNX
On Friday, Macrogenics Inc [NASDAQ:MGNX] saw its stock jump 2.03% to $3.52. Over the last five days, the stock has lost -8.09%. Macrogenics Inc shares have fallen nearly -63.41% since the year began. Nevertheless, the stocks have fallen -29.32% over the past one year. While a 52-week high of $21.88 was reached on 03/06/24, a 52-week low of $3.14 was recorded on 05/10/24. SMA at 50 days reached $4.48, while 200 days put it at $10.12. A total of 0.6 million shares were traded, compared to the trading of 0.7 million shares in the previous session.
Levels Of Support And Resistance For MGNX Stock
The 24-hour chart illustrates a support level at 3.40, which if violated will result in even more drops to 3.28. On the upside, there is a resistance level at 3.59. A further resistance level may holdings at 3.66. The Relative Strength Index (RSI) on the 14-day chart is 34.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.64%. Stochastics%K at 7.51% indicates the stock is a buying.
